InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Gillheeney Gary S., Chairman & CEO. Insider active across 1 companies, notably Organogenesis Holdings Inc.. In total, 10 filings have been published. The latest transaction was disclosed on 30 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
€477,205505,050 shares@ €0.94490.073% mcap57.2% of flow
Class A Common Stock
SEC:0001062993-22-015767:0·
€87,79994,487 shares@ €0.92920.013% mcap10.5% of flow
Class A Common Stock
SEC:0001062993-22-014294:0·
€56,45261,202 shares@ €0.92240.0086% mcap6.8% of flow
Class A Common Stock
SEC:0001062993-22-013879:0·
€6,1826,670 shares@ €0.92680.0009% mcap0.7% of flow
Class A Common Stock
SEC:0001062993-22-013521:0·
€81,79986,531 shares@ €0.94530.012% mcap9.8% of flow
Class A Common Stock
SEC:0001062993-22-013178:0·
€14,12614,810 shares@ €0.95380.0021% mcap1.7% of flow
Class A Common Stock
SEC:0001062993-22-012849:0·
€69,7559,789 shares@ €7.12590.011% mcap8.4% of flow
Class A Common Stock
SEC:0001062993-22-009815:0·
0280,199 shares0
Class A Common Stock
SEC:0001062993-22-004794:0·
€20,37824,313 shares@ €0.83810.0031% mcap100.0% of flow
Class A Common Stock
SEC:0001661181-21-000062·
€20,37824,313 shares@ €0.83810.0031% mcap2.4% of flow
Class A Common Stock
SEC:0001661181-21-000062:0·
10 of 10 declarations
About Gillheeney Gary S.
Gary S. Gillheeney is the Chairman & CEO of Organogenesis Holdings Inc. He leads the company's operations and is responsible for growth and development strategy.
